Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims
- 1 January 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 158 (1) , 140-148
Abstract
There is growing evidence that opioid prescribing in the United States follows a pattern in which patients who are at the highest risk of adverse outcomes from opioids are more likely to receive long-term opioid therapy. These patients include, in particular, those with substance use disorders (SUDs) and other psychiatric conditions. This study examined health insurance claims among 10,311,961 patients who filled prescriptions for opioids. Specifically, we evaluated how opioid receipt differed among patients with and without a wide range of preexisting psychiatric and behavioral conditions (ie, opioid and nonopioid SUDs, suicide attempts or other self-injury, motor vehicle crashes, and depressive, anxiety, and sleep disorders) and psychoactive medications (ie, antidepressants, benzodiazepines, hypnotics, mood stabilizers, antipsychotics, and medications used for SUD, tobacco cessation, and attention-deficit/hyperactivity disorder). Relative to those without, patients with all assessed psychiatric conditions and medications had modestly greater odds of subsequently filling prescriptions for opioids and, in particular, substantially greater risk of long-term opioid receipt. Increases in risk for long-term opioid receipt in adjusted Cox regressions ranged from approximately 1.5-fold for prior attention-deficit/hyperactivity disorder medication prescriptions (hazard ratio [HR] = 1.53; 95% confidence interval [CI], 1.48-1.58) to approximately 3-fold for prior nonopioid SUD diagnoses (HR = 3.15; 95% CI, 3.06-3.24) and nearly 9-fold for prior opioid use disorder diagnoses (HR = 8.70; 95% CI, 8.20-9.24). In sum, we found evidence of greater opioid receipt among commercially insured patients with a breadth of psychiatric conditions. Future studies assessing behavioral outcomes associated with opioid prescribing should consider preexisting psychiatric conditions.Keywords
This publication has 57 references indexed in Scilit:
- Dose Escalation During the First Year of Long-Term Opioid Therapy for Chronic PainPain Medicine, 2015
- Opioid therapy for chronic pain in the United States: Promises and perilsPain, 2013
- Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphineJournal of Substance Abuse Treatment, 2013
- Correlates of Prescription Opioid Initiation and Long-term Opioid Use in Veterans With Persistent PainThe Clinical Journal of Pain, 2013
- Depression, Chronic Pain, and Suicide by Overdose: On the EdgePain Medicine, 2011
- The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults—a population‐based cohort studyPharmacoepidemiology and Drug Safety, 2010
- An Analysis of Heavy Utilizers of Opioids for Chronic Noncancer Pain in the TROUP StudyJournal of Pain and Symptom Management, 2010
- A basic study design for expedited safety signal evaluation based on electronic healthcare dataPharmacoepidemiology and Drug Safety, 2010
- Use of Self-controlled Analytical Techniques to Assess the Association Between Use of Prescription Medications and the Risk of Motor Vehicle CrashesAmerican Journal of Epidemiology, 2009
- Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid UseArchives of internal medicine (1960), 2006